[Keratomycosis - Therapy Standards and New Developments].

Abstract

Mycotic keratitis is a comparatively rare but serious ophthalmological disease, that can possibly lead to a severe loss of vision up to blindness. Over the last two decades an increase of cases with mycotic keratitis has been noticed, which is possibly caused by an increased use of soft contact lenses. This article gives an overview of the typical clinical signs and symptoms of keratomycosis, tried and tested diagnostics and therapy as well as new diagnostic and therapeutic developments and findings.

• Authors: W Behrens-Baumann, D Finis, C MacKenzie, M Roth, G Geerling
• Journal: Klinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 232 Issue 6 Pg. 754-64 (Jun 2015) ISSN: 1439-3999 [Electronic] Germany
• Vernacular Title: Keratomykose - Therapiestandards und aktuelle Entwicklungen.
• PMID: 26084964 (Publication Type: English Abstract, Journal Article, Review)
• Copyright: Georg Thieme Verlag KG Stuttgart · New York.

Chemical References

• Antifungal Agents

Topics

• Antifungal Agents (therapeutic use)
• Contact Lenses, Hydrophilic (adverse effects, microbiology)
• Evidence-Based Medicine
• Eye Infections, Fungal (drug therapy, microbiology)
• Humans
• Keratitis (diagnosis, drug therapy, microbiology)
• Treatment Outcome